AI | pharmaphorum

Skip to main content

Saturday 7 February 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

AI

Views & Analysis

CryingOutForDisruption 570x320

Pharma R&D is crying out for disruption – is AI the answer?

Artificial Intelligence (AI), big data and genomics are coming together to revolutionise drug discovery and development.

News

classic artificial intelligence concept 3d backgroun

Nearly half of life science professionals using AI - survey

But lack of technical expertise holding back projects.

Events

kcBhain_800x450_pharmaforum

Partner Content

Blockchain for Clinical Trials Forum

Setting a New Standard for Optimizing Clinical Trials

News

Phillip Hammond

Budget 2017: Artificial Intelligence funds welcome, but bold...

UK AI leader welcomes increased investment but suggests more needs to be done.

News

Google’s Verily eyes 2021 growth after £700m funding round

Google's new accelerator aims to foster AI startups

Augmedix, BrainQ, ByteFlies and Cytovale make up first accelerator cohort.

News

cancer-t-cells-16_9

MicroRNA diagnostic could be big advance in ovarian cancer

AI blood test achieves very high accuracy and specificity for detecting ovarian cancer.

Load more results

Editor's Picks

AZ deepens Chinese ties, signs $18.5bn CSPC obesity deal

GLP-1 drugs linked to pancreatitis, gallbladder problems

UK biotech sees "strong finish" to 2025 financing

CMS's Medicare price negotiations start round three

Vaccination fall costs UK its measles elimination status

R&D

Interview at JPM26 Sam Possemiers

The long-delayed promise of the microbiome, with Sam Possemi...

Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

Sponsored

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company